Next Article in Journal
The Effectiveness of a Foot and Mouth Disease Outbreak Control Programme in Thailand 2008–2015: Case Studies and Lessons Learned
Previous Article in Journal
Analysis of Final Year Veterinary Students’ Telephone Communication Skills at a Veterinary Teaching Hospital
Previous Article in Special Issue
The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients

Cellular Immunotherapy of Canine Cancer

Nantkwest Inc., Culver City, CA 99232, USA
Author to whom correspondence should be addressed.
Vet. Sci. 2018, 5(4), 100;
Received: 13 July 2018 / Revised: 11 November 2018 / Accepted: 30 November 2018 / Published: 6 December 2018
(This article belongs to the Special Issue Canine Cancer Immunotherapeutics)
Infusions with immune cells, such as lymphocytes or natural killer (NK) cells, represent one of several modalities of immunotherapy. In human patients with advanced B-cell leukemia or lymphoma, infusions with chimeric antigen receptor (CAR) T-lymphocytes have shown promising responses. However, the scientific and clinical development of cell-based therapies for dogs, who get cancer of similar types as humans, is lagging behind. One reason is that immune cells and their functionality in dogs are less well characterized, largely due a lack of canine-specific reagents to detect surface markers, and specific cytokines to isolate and expand their immune cells. This review summarizes the current status of canine cancer immunotherapies, with focus on autologous and allogeneic T-lymphocytes, as well as NK cells, and discusses potential initiatives that would allow therapies with canine immune cells to “catch up” with the advances in humans. View Full-Text
Keywords: canine immunotherapy; lymphocytes; natural killer cells; chimeric antigen receptors canine immunotherapy; lymphocytes; natural killer cells; chimeric antigen receptors
Show Figures

Figure 1

MDPI and ACS Style

Addissie, S.; Klingemann, H. Cellular Immunotherapy of Canine Cancer. Vet. Sci. 2018, 5, 100.

AMA Style

Addissie S, Klingemann H. Cellular Immunotherapy of Canine Cancer. Veterinary Sciences. 2018; 5(4):100.

Chicago/Turabian Style

Addissie, Selamawit, and Hans Klingemann. 2018. "Cellular Immunotherapy of Canine Cancer" Veterinary Sciences 5, no. 4: 100.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop